{"transactions":[{"id":1839970,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:56:52.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":70200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement."}],"balance_after":70200,"derivative":{"exercise_price":0.5891,"exercise_date":"2026-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":70200},"source":{"system":"sec-edgar","filing":"0001104659-23-077656","document":"tm2320411-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077656/tm2320411-5_4seq1.xml","form_type":"4"}},{"id":2036691,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-02T21:17:17.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":31200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 31,200 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement."}],"balance_after":31200,"source":{"system":"sec-edgar","filing":"0001104659-23-009908","document":"tm235262-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923009908/tm235262-1_4seq1.xml","form_type":"4"}},{"id":2472020,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-15T21:18:49.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":100000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-150000","document":"tm2135363d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150000/tm2135363d1_4.xml","form_type":"4"}},{"id":2998751,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-28T20:12:25.000Z","date":"2020-10-23","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 40,000 shares on October 23, 2021, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":3.77,"expiration_date":"2030-10-23","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-20-118939","document":"tm2034345d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465920118939/tm2034345d2_4.xml","form_type":"4"}}]}